Skip to main content

Main menu

  • Home
  • Content
    • First Release
    • Current
    • Archives
    • Collections
    • Audiovisual Rheum
    • 50th Volume Reprints
  • Resources
    • Guide for Authors
    • Submit Manuscript
    • Payment
    • Reviewers
    • Advertisers
    • Classified Ads
    • Reprints and Translations
    • Permissions
    • Meetings
    • FAQ
    • Policies
  • Subscribers
    • Subscription Information
    • Purchase Subscription
    • Your Account
    • Terms and Conditions
  • About Us
    • About Us
    • Editorial Board
    • Letter from the Editor
    • Duncan A. Gordon Award
    • Privacy/GDPR Policy
    • Accessibility
  • Contact Us
  • JRheum Supplements
  • Services

User menu

  • My Cart
  • Log In

Search

  • Advanced search
The Journal of Rheumatology
  • JRheum Supplements
  • Services
  • My Cart
  • Log In
The Journal of Rheumatology

Advanced Search

  • Home
  • Content
    • First Release
    • Current
    • Archives
    • Collections
    • Audiovisual Rheum
    • 50th Volume Reprints
  • Resources
    • Guide for Authors
    • Submit Manuscript
    • Payment
    • Reviewers
    • Advertisers
    • Classified Ads
    • Reprints and Translations
    • Permissions
    • Meetings
    • FAQ
    • Policies
  • Subscribers
    • Subscription Information
    • Purchase Subscription
    • Your Account
    • Terms and Conditions
  • About Us
    • About Us
    • Editorial Board
    • Letter from the Editor
    • Duncan A. Gordon Award
    • Privacy/GDPR Policy
    • Accessibility
  • Contact Us
  • Follow Jrheum on BlueSky
  • Follow jrheum on Twitter
  • Visit jrheum on Facebook
  • Follow jrheum on LinkedIn
  • Follow jrheum on YouTube
  • Follow jrheum on Instagram
  • Follow jrheum on RSS
Research ArticleAccepted Articles

Impact of communicative and critical health literacy on trust in physicians among patients with systemic lupus erythematosus: the TRUMP2-SLE project

Nao Oguro, Nobuyuki Yajima, Yoshia Miyawaki, Ryusuke Yoshimi, Yasuhiro Shimojima, Ken-ei Sada, Keigo Hayashi, Kenta Shidahara, Natsuki Sakurai, Chiharu Hidekawa, Dai Kishida, Takanori Ichikawa, Yuichi Ishikawa and Noriaki Kurita
The Journal of Rheumatology November 2022, jrheum.220678; DOI: https://doi.org/10.3899/jrheum.220678
Nao Oguro
Sources of support: This study was supported by the JSPS KAKENHI (Grant Number: JP 19KT0021). The funder had no role in the study design, analyses, or interpretation of the data; writing of the manuscript; or the decision to submit it for publication. Oguro, N., MD, PhD. Division of Rheumatology, Department of Medicine, Showa University School of Medicine; Department of Clinical Epidemiology, Graduate School of Medicine, Fukushima Medical University. Yajima, N., MD, PhD. Division of Rheumatology, Department of Medicine, Showa University School of Medicine; Center for Innovative Research for Communities and Clinical Excellence, Fukushima Medical University; Department of Clinical Epidemiology, Kochi Medical School, Kochi University. Miyawaki, Y., MD, PhD. Department of Nephrology, Rheumatology, Endocrinology and Metabolism, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences. Yoshimi, R., MD, PhD. Department of Stem Cell and Immune Regulation, Yokohama City University Graduate School of Medicine. Shimojima Y., MD, PhD. Department of Medicine (Neurology and Rheumatology), Shinshu University School of Medicine. Sada K., MD, PhD. Department of Nephrology, Rheumatology, Endocrinology and Metabolism, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences; Department of Clinical Epidemiology, Kochi Medical School, Kochi University. Hayashi K., MD, PhD. Department of Nephrology, Rheumatology, Endocrinology and Metabolism, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences. Shidahara, K., MD. Department of Nephrology, Rheumatology, Endocrinology and Metabolism, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences. Sakurai N., MD. Department of Stem Cell and Immune Regulation, Yokohama City University Graduate School of Medicine. Hidekawa C., MD. Center for Rheumatic Diseases, Yokohama City University Medical Center. Kishida D., MD, PhD. Department of Medicine (Neurology and Rheumatology), Shinshu University School of Medicine. Ichikawa T., MD, PhD. Department of Medicine (Neurology and Rheumatology), Shinshu University School of Medicine. Ishikawa Y., MD. The First Department of Internal Medicine, School of Medicine, University of Occupational and Environmental Health. Kurita N., MD, PhD. Department of Clinical Epidemiology, Graduate School of Medicine, Fukushima Medical University; Department of Innovative Research and Education for Clinicians and Trainees (DiRECT), Fukushima Medical University Hospital. Conflict of interests: NK is a member of the Committee on Clinical Research, Japan College of Rheumatology and has received grants from the Japan Society for the Promotion of Science, consulting fees from GlaxoSmithKline K.K., and payment for speaking and educational events from Chugai Pharmaceutical Co. Ltd., Sanofi K.K., Mitsubishi Tanabe Pharma Corporation, and the Japan College of Rheumatology. KS has received a research grant from Pfizer Inc. and payment for speaking and educational events from GlaxoSmithKline K.K. Other authors declare no competing interests. Corresponding author: Noriaki Kurita, MD, PhD, FACP Department of Clinical Epidemiology, Graduate School of Medicine, Fukushima Medical University, 1 Hikarigaoka, Fukushima City, Fukushima 960-1295, Japan kuritanoriaki@gmail.com
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Nobuyuki Yajima
Sources of support: This study was supported by the JSPS KAKENHI (Grant Number: JP 19KT0021). The funder had no role in the study design, analyses, or interpretation of the data; writing of the manuscript; or the decision to submit it for publication. Oguro, N., MD, PhD. Division of Rheumatology, Department of Medicine, Showa University School of Medicine; Department of Clinical Epidemiology, Graduate School of Medicine, Fukushima Medical University. Yajima, N., MD, PhD. Division of Rheumatology, Department of Medicine, Showa University School of Medicine; Center for Innovative Research for Communities and Clinical Excellence, Fukushima Medical University; Department of Clinical Epidemiology, Kochi Medical School, Kochi University. Miyawaki, Y., MD, PhD. Department of Nephrology, Rheumatology, Endocrinology and Metabolism, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences. Yoshimi, R., MD, PhD. Department of Stem Cell and Immune Regulation, Yokohama City University Graduate School of Medicine. Shimojima Y., MD, PhD. Department of Medicine (Neurology and Rheumatology), Shinshu University School of Medicine. Sada K., MD, PhD. Department of Nephrology, Rheumatology, Endocrinology and Metabolism, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences; Department of Clinical Epidemiology, Kochi Medical School, Kochi University. Hayashi K., MD, PhD. Department of Nephrology, Rheumatology, Endocrinology and Metabolism, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences. Shidahara, K., MD. Department of Nephrology, Rheumatology, Endocrinology and Metabolism, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences. Sakurai N., MD. Department of Stem Cell and Immune Regulation, Yokohama City University Graduate School of Medicine. Hidekawa C., MD. Center for Rheumatic Diseases, Yokohama City University Medical Center. Kishida D., MD, PhD. Department of Medicine (Neurology and Rheumatology), Shinshu University School of Medicine. Ichikawa T., MD, PhD. Department of Medicine (Neurology and Rheumatology), Shinshu University School of Medicine. Ishikawa Y., MD. The First Department of Internal Medicine, School of Medicine, University of Occupational and Environmental Health. Kurita N., MD, PhD. Department of Clinical Epidemiology, Graduate School of Medicine, Fukushima Medical University; Department of Innovative Research and Education for Clinicians and Trainees (DiRECT), Fukushima Medical University Hospital. Conflict of interests: NK is a member of the Committee on Clinical Research, Japan College of Rheumatology and has received grants from the Japan Society for the Promotion of Science, consulting fees from GlaxoSmithKline K.K., and payment for speaking and educational events from Chugai Pharmaceutical Co. Ltd., Sanofi K.K., Mitsubishi Tanabe Pharma Corporation, and the Japan College of Rheumatology. KS has received a research grant from Pfizer Inc. and payment for speaking and educational events from GlaxoSmithKline K.K. Other authors declare no competing interests. Corresponding author: Noriaki Kurita, MD, PhD, FACP Department of Clinical Epidemiology, Graduate School of Medicine, Fukushima Medical University, 1 Hikarigaoka, Fukushima City, Fukushima 960-1295, Japan kuritanoriaki@gmail.com
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Yoshia Miyawaki
Sources of support: This study was supported by the JSPS KAKENHI (Grant Number: JP 19KT0021). The funder had no role in the study design, analyses, or interpretation of the data; writing of the manuscript; or the decision to submit it for publication. Oguro, N., MD, PhD. Division of Rheumatology, Department of Medicine, Showa University School of Medicine; Department of Clinical Epidemiology, Graduate School of Medicine, Fukushima Medical University. Yajima, N., MD, PhD. Division of Rheumatology, Department of Medicine, Showa University School of Medicine; Center for Innovative Research for Communities and Clinical Excellence, Fukushima Medical University; Department of Clinical Epidemiology, Kochi Medical School, Kochi University. Miyawaki, Y., MD, PhD. Department of Nephrology, Rheumatology, Endocrinology and Metabolism, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences. Yoshimi, R., MD, PhD. Department of Stem Cell and Immune Regulation, Yokohama City University Graduate School of Medicine. Shimojima Y., MD, PhD. Department of Medicine (Neurology and Rheumatology), Shinshu University School of Medicine. Sada K., MD, PhD. Department of Nephrology, Rheumatology, Endocrinology and Metabolism, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences; Department of Clinical Epidemiology, Kochi Medical School, Kochi University. Hayashi K., MD, PhD. Department of Nephrology, Rheumatology, Endocrinology and Metabolism, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences. Shidahara, K., MD. Department of Nephrology, Rheumatology, Endocrinology and Metabolism, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences. Sakurai N., MD. Department of Stem Cell and Immune Regulation, Yokohama City University Graduate School of Medicine. Hidekawa C., MD. Center for Rheumatic Diseases, Yokohama City University Medical Center. Kishida D., MD, PhD. Department of Medicine (Neurology and Rheumatology), Shinshu University School of Medicine. Ichikawa T., MD, PhD. Department of Medicine (Neurology and Rheumatology), Shinshu University School of Medicine. Ishikawa Y., MD. The First Department of Internal Medicine, School of Medicine, University of Occupational and Environmental Health. Kurita N., MD, PhD. Department of Clinical Epidemiology, Graduate School of Medicine, Fukushima Medical University; Department of Innovative Research and Education for Clinicians and Trainees (DiRECT), Fukushima Medical University Hospital. Conflict of interests: NK is a member of the Committee on Clinical Research, Japan College of Rheumatology and has received grants from the Japan Society for the Promotion of Science, consulting fees from GlaxoSmithKline K.K., and payment for speaking and educational events from Chugai Pharmaceutical Co. Ltd., Sanofi K.K., Mitsubishi Tanabe Pharma Corporation, and the Japan College of Rheumatology. KS has received a research grant from Pfizer Inc. and payment for speaking and educational events from GlaxoSmithKline K.K. Other authors declare no competing interests. Corresponding author: Noriaki Kurita, MD, PhD, FACP Department of Clinical Epidemiology, Graduate School of Medicine, Fukushima Medical University, 1 Hikarigaoka, Fukushima City, Fukushima 960-1295, Japan kuritanoriaki@gmail.com
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Ryusuke Yoshimi
Sources of support: This study was supported by the JSPS KAKENHI (Grant Number: JP 19KT0021). The funder had no role in the study design, analyses, or interpretation of the data; writing of the manuscript; or the decision to submit it for publication. Oguro, N., MD, PhD. Division of Rheumatology, Department of Medicine, Showa University School of Medicine; Department of Clinical Epidemiology, Graduate School of Medicine, Fukushima Medical University. Yajima, N., MD, PhD. Division of Rheumatology, Department of Medicine, Showa University School of Medicine; Center for Innovative Research for Communities and Clinical Excellence, Fukushima Medical University; Department of Clinical Epidemiology, Kochi Medical School, Kochi University. Miyawaki, Y., MD, PhD. Department of Nephrology, Rheumatology, Endocrinology and Metabolism, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences. Yoshimi, R., MD, PhD. Department of Stem Cell and Immune Regulation, Yokohama City University Graduate School of Medicine. Shimojima Y., MD, PhD. Department of Medicine (Neurology and Rheumatology), Shinshu University School of Medicine. Sada K., MD, PhD. Department of Nephrology, Rheumatology, Endocrinology and Metabolism, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences; Department of Clinical Epidemiology, Kochi Medical School, Kochi University. Hayashi K., MD, PhD. Department of Nephrology, Rheumatology, Endocrinology and Metabolism, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences. Shidahara, K., MD. Department of Nephrology, Rheumatology, Endocrinology and Metabolism, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences. Sakurai N., MD. Department of Stem Cell and Immune Regulation, Yokohama City University Graduate School of Medicine. Hidekawa C., MD. Center for Rheumatic Diseases, Yokohama City University Medical Center. Kishida D., MD, PhD. Department of Medicine (Neurology and Rheumatology), Shinshu University School of Medicine. Ichikawa T., MD, PhD. Department of Medicine (Neurology and Rheumatology), Shinshu University School of Medicine. Ishikawa Y., MD. The First Department of Internal Medicine, School of Medicine, University of Occupational and Environmental Health. Kurita N., MD, PhD. Department of Clinical Epidemiology, Graduate School of Medicine, Fukushima Medical University; Department of Innovative Research and Education for Clinicians and Trainees (DiRECT), Fukushima Medical University Hospital. Conflict of interests: NK is a member of the Committee on Clinical Research, Japan College of Rheumatology and has received grants from the Japan Society for the Promotion of Science, consulting fees from GlaxoSmithKline K.K., and payment for speaking and educational events from Chugai Pharmaceutical Co. Ltd., Sanofi K.K., Mitsubishi Tanabe Pharma Corporation, and the Japan College of Rheumatology. KS has received a research grant from Pfizer Inc. and payment for speaking and educational events from GlaxoSmithKline K.K. Other authors declare no competing interests. Corresponding author: Noriaki Kurita, MD, PhD, FACP Department of Clinical Epidemiology, Graduate School of Medicine, Fukushima Medical University, 1 Hikarigaoka, Fukushima City, Fukushima 960-1295, Japan kuritanoriaki@gmail.com
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Yasuhiro Shimojima
Sources of support: This study was supported by the JSPS KAKENHI (Grant Number: JP 19KT0021). The funder had no role in the study design, analyses, or interpretation of the data; writing of the manuscript; or the decision to submit it for publication. Oguro, N., MD, PhD. Division of Rheumatology, Department of Medicine, Showa University School of Medicine; Department of Clinical Epidemiology, Graduate School of Medicine, Fukushima Medical University. Yajima, N., MD, PhD. Division of Rheumatology, Department of Medicine, Showa University School of Medicine; Center for Innovative Research for Communities and Clinical Excellence, Fukushima Medical University; Department of Clinical Epidemiology, Kochi Medical School, Kochi University. Miyawaki, Y., MD, PhD. Department of Nephrology, Rheumatology, Endocrinology and Metabolism, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences. Yoshimi, R., MD, PhD. Department of Stem Cell and Immune Regulation, Yokohama City University Graduate School of Medicine. Shimojima Y., MD, PhD. Department of Medicine (Neurology and Rheumatology), Shinshu University School of Medicine. Sada K., MD, PhD. Department of Nephrology, Rheumatology, Endocrinology and Metabolism, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences; Department of Clinical Epidemiology, Kochi Medical School, Kochi University. Hayashi K., MD, PhD. Department of Nephrology, Rheumatology, Endocrinology and Metabolism, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences. Shidahara, K., MD. Department of Nephrology, Rheumatology, Endocrinology and Metabolism, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences. Sakurai N., MD. Department of Stem Cell and Immune Regulation, Yokohama City University Graduate School of Medicine. Hidekawa C., MD. Center for Rheumatic Diseases, Yokohama City University Medical Center. Kishida D., MD, PhD. Department of Medicine (Neurology and Rheumatology), Shinshu University School of Medicine. Ichikawa T., MD, PhD. Department of Medicine (Neurology and Rheumatology), Shinshu University School of Medicine. Ishikawa Y., MD. The First Department of Internal Medicine, School of Medicine, University of Occupational and Environmental Health. Kurita N., MD, PhD. Department of Clinical Epidemiology, Graduate School of Medicine, Fukushima Medical University; Department of Innovative Research and Education for Clinicians and Trainees (DiRECT), Fukushima Medical University Hospital. Conflict of interests: NK is a member of the Committee on Clinical Research, Japan College of Rheumatology and has received grants from the Japan Society for the Promotion of Science, consulting fees from GlaxoSmithKline K.K., and payment for speaking and educational events from Chugai Pharmaceutical Co. Ltd., Sanofi K.K., Mitsubishi Tanabe Pharma Corporation, and the Japan College of Rheumatology. KS has received a research grant from Pfizer Inc. and payment for speaking and educational events from GlaxoSmithKline K.K. Other authors declare no competing interests. Corresponding author: Noriaki Kurita, MD, PhD, FACP Department of Clinical Epidemiology, Graduate School of Medicine, Fukushima Medical University, 1 Hikarigaoka, Fukushima City, Fukushima 960-1295, Japan kuritanoriaki@gmail.com
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Ken-ei Sada
Sources of support: This study was supported by the JSPS KAKENHI (Grant Number: JP 19KT0021). The funder had no role in the study design, analyses, or interpretation of the data; writing of the manuscript; or the decision to submit it for publication. Oguro, N., MD, PhD. Division of Rheumatology, Department of Medicine, Showa University School of Medicine; Department of Clinical Epidemiology, Graduate School of Medicine, Fukushima Medical University. Yajima, N., MD, PhD. Division of Rheumatology, Department of Medicine, Showa University School of Medicine; Center for Innovative Research for Communities and Clinical Excellence, Fukushima Medical University; Department of Clinical Epidemiology, Kochi Medical School, Kochi University. Miyawaki, Y., MD, PhD. Department of Nephrology, Rheumatology, Endocrinology and Metabolism, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences. Yoshimi, R., MD, PhD. Department of Stem Cell and Immune Regulation, Yokohama City University Graduate School of Medicine. Shimojima Y., MD, PhD. Department of Medicine (Neurology and Rheumatology), Shinshu University School of Medicine. Sada K., MD, PhD. Department of Nephrology, Rheumatology, Endocrinology and Metabolism, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences; Department of Clinical Epidemiology, Kochi Medical School, Kochi University. Hayashi K., MD, PhD. Department of Nephrology, Rheumatology, Endocrinology and Metabolism, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences. Shidahara, K., MD. Department of Nephrology, Rheumatology, Endocrinology and Metabolism, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences. Sakurai N., MD. Department of Stem Cell and Immune Regulation, Yokohama City University Graduate School of Medicine. Hidekawa C., MD. Center for Rheumatic Diseases, Yokohama City University Medical Center. Kishida D., MD, PhD. Department of Medicine (Neurology and Rheumatology), Shinshu University School of Medicine. Ichikawa T., MD, PhD. Department of Medicine (Neurology and Rheumatology), Shinshu University School of Medicine. Ishikawa Y., MD. The First Department of Internal Medicine, School of Medicine, University of Occupational and Environmental Health. Kurita N., MD, PhD. Department of Clinical Epidemiology, Graduate School of Medicine, Fukushima Medical University; Department of Innovative Research and Education for Clinicians and Trainees (DiRECT), Fukushima Medical University Hospital. Conflict of interests: NK is a member of the Committee on Clinical Research, Japan College of Rheumatology and has received grants from the Japan Society for the Promotion of Science, consulting fees from GlaxoSmithKline K.K., and payment for speaking and educational events from Chugai Pharmaceutical Co. Ltd., Sanofi K.K., Mitsubishi Tanabe Pharma Corporation, and the Japan College of Rheumatology. KS has received a research grant from Pfizer Inc. and payment for speaking and educational events from GlaxoSmithKline K.K. Other authors declare no competing interests. Corresponding author: Noriaki Kurita, MD, PhD, FACP Department of Clinical Epidemiology, Graduate School of Medicine, Fukushima Medical University, 1 Hikarigaoka, Fukushima City, Fukushima 960-1295, Japan kuritanoriaki@gmail.com
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Keigo Hayashi
Sources of support: This study was supported by the JSPS KAKENHI (Grant Number: JP 19KT0021). The funder had no role in the study design, analyses, or interpretation of the data; writing of the manuscript; or the decision to submit it for publication. Oguro, N., MD, PhD. Division of Rheumatology, Department of Medicine, Showa University School of Medicine; Department of Clinical Epidemiology, Graduate School of Medicine, Fukushima Medical University. Yajima, N., MD, PhD. Division of Rheumatology, Department of Medicine, Showa University School of Medicine; Center for Innovative Research for Communities and Clinical Excellence, Fukushima Medical University; Department of Clinical Epidemiology, Kochi Medical School, Kochi University. Miyawaki, Y., MD, PhD. Department of Nephrology, Rheumatology, Endocrinology and Metabolism, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences. Yoshimi, R., MD, PhD. Department of Stem Cell and Immune Regulation, Yokohama City University Graduate School of Medicine. Shimojima Y., MD, PhD. Department of Medicine (Neurology and Rheumatology), Shinshu University School of Medicine. Sada K., MD, PhD. Department of Nephrology, Rheumatology, Endocrinology and Metabolism, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences; Department of Clinical Epidemiology, Kochi Medical School, Kochi University. Hayashi K., MD, PhD. Department of Nephrology, Rheumatology, Endocrinology and Metabolism, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences. Shidahara, K., MD. Department of Nephrology, Rheumatology, Endocrinology and Metabolism, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences. Sakurai N., MD. Department of Stem Cell and Immune Regulation, Yokohama City University Graduate School of Medicine. Hidekawa C., MD. Center for Rheumatic Diseases, Yokohama City University Medical Center. Kishida D., MD, PhD. Department of Medicine (Neurology and Rheumatology), Shinshu University School of Medicine. Ichikawa T., MD, PhD. Department of Medicine (Neurology and Rheumatology), Shinshu University School of Medicine. Ishikawa Y., MD. The First Department of Internal Medicine, School of Medicine, University of Occupational and Environmental Health. Kurita N., MD, PhD. Department of Clinical Epidemiology, Graduate School of Medicine, Fukushima Medical University; Department of Innovative Research and Education for Clinicians and Trainees (DiRECT), Fukushima Medical University Hospital. Conflict of interests: NK is a member of the Committee on Clinical Research, Japan College of Rheumatology and has received grants from the Japan Society for the Promotion of Science, consulting fees from GlaxoSmithKline K.K., and payment for speaking and educational events from Chugai Pharmaceutical Co. Ltd., Sanofi K.K., Mitsubishi Tanabe Pharma Corporation, and the Japan College of Rheumatology. KS has received a research grant from Pfizer Inc. and payment for speaking and educational events from GlaxoSmithKline K.K. Other authors declare no competing interests. Corresponding author: Noriaki Kurita, MD, PhD, FACP Department of Clinical Epidemiology, Graduate School of Medicine, Fukushima Medical University, 1 Hikarigaoka, Fukushima City, Fukushima 960-1295, Japan kuritanoriaki@gmail.com
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Kenta Shidahara
Sources of support: This study was supported by the JSPS KAKENHI (Grant Number: JP 19KT0021). The funder had no role in the study design, analyses, or interpretation of the data; writing of the manuscript; or the decision to submit it for publication. Oguro, N., MD, PhD. Division of Rheumatology, Department of Medicine, Showa University School of Medicine; Department of Clinical Epidemiology, Graduate School of Medicine, Fukushima Medical University. Yajima, N., MD, PhD. Division of Rheumatology, Department of Medicine, Showa University School of Medicine; Center for Innovative Research for Communities and Clinical Excellence, Fukushima Medical University; Department of Clinical Epidemiology, Kochi Medical School, Kochi University. Miyawaki, Y., MD, PhD. Department of Nephrology, Rheumatology, Endocrinology and Metabolism, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences. Yoshimi, R., MD, PhD. Department of Stem Cell and Immune Regulation, Yokohama City University Graduate School of Medicine. Shimojima Y., MD, PhD. Department of Medicine (Neurology and Rheumatology), Shinshu University School of Medicine. Sada K., MD, PhD. Department of Nephrology, Rheumatology, Endocrinology and Metabolism, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences; Department of Clinical Epidemiology, Kochi Medical School, Kochi University. Hayashi K., MD, PhD. Department of Nephrology, Rheumatology, Endocrinology and Metabolism, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences. Shidahara, K., MD. Department of Nephrology, Rheumatology, Endocrinology and Metabolism, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences. Sakurai N., MD. Department of Stem Cell and Immune Regulation, Yokohama City University Graduate School of Medicine. Hidekawa C., MD. Center for Rheumatic Diseases, Yokohama City University Medical Center. Kishida D., MD, PhD. Department of Medicine (Neurology and Rheumatology), Shinshu University School of Medicine. Ichikawa T., MD, PhD. Department of Medicine (Neurology and Rheumatology), Shinshu University School of Medicine. Ishikawa Y., MD. The First Department of Internal Medicine, School of Medicine, University of Occupational and Environmental Health. Kurita N., MD, PhD. Department of Clinical Epidemiology, Graduate School of Medicine, Fukushima Medical University; Department of Innovative Research and Education for Clinicians and Trainees (DiRECT), Fukushima Medical University Hospital. Conflict of interests: NK is a member of the Committee on Clinical Research, Japan College of Rheumatology and has received grants from the Japan Society for the Promotion of Science, consulting fees from GlaxoSmithKline K.K., and payment for speaking and educational events from Chugai Pharmaceutical Co. Ltd., Sanofi K.K., Mitsubishi Tanabe Pharma Corporation, and the Japan College of Rheumatology. KS has received a research grant from Pfizer Inc. and payment for speaking and educational events from GlaxoSmithKline K.K. Other authors declare no competing interests. Corresponding author: Noriaki Kurita, MD, PhD, FACP Department of Clinical Epidemiology, Graduate School of Medicine, Fukushima Medical University, 1 Hikarigaoka, Fukushima City, Fukushima 960-1295, Japan kuritanoriaki@gmail.com
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Natsuki Sakurai
Sources of support: This study was supported by the JSPS KAKENHI (Grant Number: JP 19KT0021). The funder had no role in the study design, analyses, or interpretation of the data; writing of the manuscript; or the decision to submit it for publication. Oguro, N., MD, PhD. Division of Rheumatology, Department of Medicine, Showa University School of Medicine; Department of Clinical Epidemiology, Graduate School of Medicine, Fukushima Medical University. Yajima, N., MD, PhD. Division of Rheumatology, Department of Medicine, Showa University School of Medicine; Center for Innovative Research for Communities and Clinical Excellence, Fukushima Medical University; Department of Clinical Epidemiology, Kochi Medical School, Kochi University. Miyawaki, Y., MD, PhD. Department of Nephrology, Rheumatology, Endocrinology and Metabolism, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences. Yoshimi, R., MD, PhD. Department of Stem Cell and Immune Regulation, Yokohama City University Graduate School of Medicine. Shimojima Y., MD, PhD. Department of Medicine (Neurology and Rheumatology), Shinshu University School of Medicine. Sada K., MD, PhD. Department of Nephrology, Rheumatology, Endocrinology and Metabolism, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences; Department of Clinical Epidemiology, Kochi Medical School, Kochi University. Hayashi K., MD, PhD. Department of Nephrology, Rheumatology, Endocrinology and Metabolism, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences. Shidahara, K., MD. Department of Nephrology, Rheumatology, Endocrinology and Metabolism, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences. Sakurai N., MD. Department of Stem Cell and Immune Regulation, Yokohama City University Graduate School of Medicine. Hidekawa C., MD. Center for Rheumatic Diseases, Yokohama City University Medical Center. Kishida D., MD, PhD. Department of Medicine (Neurology and Rheumatology), Shinshu University School of Medicine. Ichikawa T., MD, PhD. Department of Medicine (Neurology and Rheumatology), Shinshu University School of Medicine. Ishikawa Y., MD. The First Department of Internal Medicine, School of Medicine, University of Occupational and Environmental Health. Kurita N., MD, PhD. Department of Clinical Epidemiology, Graduate School of Medicine, Fukushima Medical University; Department of Innovative Research and Education for Clinicians and Trainees (DiRECT), Fukushima Medical University Hospital. Conflict of interests: NK is a member of the Committee on Clinical Research, Japan College of Rheumatology and has received grants from the Japan Society for the Promotion of Science, consulting fees from GlaxoSmithKline K.K., and payment for speaking and educational events from Chugai Pharmaceutical Co. Ltd., Sanofi K.K., Mitsubishi Tanabe Pharma Corporation, and the Japan College of Rheumatology. KS has received a research grant from Pfizer Inc. and payment for speaking and educational events from GlaxoSmithKline K.K. Other authors declare no competing interests. Corresponding author: Noriaki Kurita, MD, PhD, FACP Department of Clinical Epidemiology, Graduate School of Medicine, Fukushima Medical University, 1 Hikarigaoka, Fukushima City, Fukushima 960-1295, Japan kuritanoriaki@gmail.com
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Chiharu Hidekawa
Sources of support: This study was supported by the JSPS KAKENHI (Grant Number: JP 19KT0021). The funder had no role in the study design, analyses, or interpretation of the data; writing of the manuscript; or the decision to submit it for publication. Oguro, N., MD, PhD. Division of Rheumatology, Department of Medicine, Showa University School of Medicine; Department of Clinical Epidemiology, Graduate School of Medicine, Fukushima Medical University. Yajima, N., MD, PhD. Division of Rheumatology, Department of Medicine, Showa University School of Medicine; Center for Innovative Research for Communities and Clinical Excellence, Fukushima Medical University; Department of Clinical Epidemiology, Kochi Medical School, Kochi University. Miyawaki, Y., MD, PhD. Department of Nephrology, Rheumatology, Endocrinology and Metabolism, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences. Yoshimi, R., MD, PhD. Department of Stem Cell and Immune Regulation, Yokohama City University Graduate School of Medicine. Shimojima Y., MD, PhD. Department of Medicine (Neurology and Rheumatology), Shinshu University School of Medicine. Sada K., MD, PhD. Department of Nephrology, Rheumatology, Endocrinology and Metabolism, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences; Department of Clinical Epidemiology, Kochi Medical School, Kochi University. Hayashi K., MD, PhD. Department of Nephrology, Rheumatology, Endocrinology and Metabolism, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences. Shidahara, K., MD. Department of Nephrology, Rheumatology, Endocrinology and Metabolism, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences. Sakurai N., MD. Department of Stem Cell and Immune Regulation, Yokohama City University Graduate School of Medicine. Hidekawa C., MD. Center for Rheumatic Diseases, Yokohama City University Medical Center. Kishida D., MD, PhD. Department of Medicine (Neurology and Rheumatology), Shinshu University School of Medicine. Ichikawa T., MD, PhD. Department of Medicine (Neurology and Rheumatology), Shinshu University School of Medicine. Ishikawa Y., MD. The First Department of Internal Medicine, School of Medicine, University of Occupational and Environmental Health. Kurita N., MD, PhD. Department of Clinical Epidemiology, Graduate School of Medicine, Fukushima Medical University; Department of Innovative Research and Education for Clinicians and Trainees (DiRECT), Fukushima Medical University Hospital. Conflict of interests: NK is a member of the Committee on Clinical Research, Japan College of Rheumatology and has received grants from the Japan Society for the Promotion of Science, consulting fees from GlaxoSmithKline K.K., and payment for speaking and educational events from Chugai Pharmaceutical Co. Ltd., Sanofi K.K., Mitsubishi Tanabe Pharma Corporation, and the Japan College of Rheumatology. KS has received a research grant from Pfizer Inc. and payment for speaking and educational events from GlaxoSmithKline K.K. Other authors declare no competing interests. Corresponding author: Noriaki Kurita, MD, PhD, FACP Department of Clinical Epidemiology, Graduate School of Medicine, Fukushima Medical University, 1 Hikarigaoka, Fukushima City, Fukushima 960-1295, Japan kuritanoriaki@gmail.com
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Dai Kishida
Sources of support: This study was supported by the JSPS KAKENHI (Grant Number: JP 19KT0021). The funder had no role in the study design, analyses, or interpretation of the data; writing of the manuscript; or the decision to submit it for publication. Oguro, N., MD, PhD. Division of Rheumatology, Department of Medicine, Showa University School of Medicine; Department of Clinical Epidemiology, Graduate School of Medicine, Fukushima Medical University. Yajima, N., MD, PhD. Division of Rheumatology, Department of Medicine, Showa University School of Medicine; Center for Innovative Research for Communities and Clinical Excellence, Fukushima Medical University; Department of Clinical Epidemiology, Kochi Medical School, Kochi University. Miyawaki, Y., MD, PhD. Department of Nephrology, Rheumatology, Endocrinology and Metabolism, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences. Yoshimi, R., MD, PhD. Department of Stem Cell and Immune Regulation, Yokohama City University Graduate School of Medicine. Shimojima Y., MD, PhD. Department of Medicine (Neurology and Rheumatology), Shinshu University School of Medicine. Sada K., MD, PhD. Department of Nephrology, Rheumatology, Endocrinology and Metabolism, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences; Department of Clinical Epidemiology, Kochi Medical School, Kochi University. Hayashi K., MD, PhD. Department of Nephrology, Rheumatology, Endocrinology and Metabolism, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences. Shidahara, K., MD. Department of Nephrology, Rheumatology, Endocrinology and Metabolism, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences. Sakurai N., MD. Department of Stem Cell and Immune Regulation, Yokohama City University Graduate School of Medicine. Hidekawa C., MD. Center for Rheumatic Diseases, Yokohama City University Medical Center. Kishida D., MD, PhD. Department of Medicine (Neurology and Rheumatology), Shinshu University School of Medicine. Ichikawa T., MD, PhD. Department of Medicine (Neurology and Rheumatology), Shinshu University School of Medicine. Ishikawa Y., MD. The First Department of Internal Medicine, School of Medicine, University of Occupational and Environmental Health. Kurita N., MD, PhD. Department of Clinical Epidemiology, Graduate School of Medicine, Fukushima Medical University; Department of Innovative Research and Education for Clinicians and Trainees (DiRECT), Fukushima Medical University Hospital. Conflict of interests: NK is a member of the Committee on Clinical Research, Japan College of Rheumatology and has received grants from the Japan Society for the Promotion of Science, consulting fees from GlaxoSmithKline K.K., and payment for speaking and educational events from Chugai Pharmaceutical Co. Ltd., Sanofi K.K., Mitsubishi Tanabe Pharma Corporation, and the Japan College of Rheumatology. KS has received a research grant from Pfizer Inc. and payment for speaking and educational events from GlaxoSmithKline K.K. Other authors declare no competing interests. Corresponding author: Noriaki Kurita, MD, PhD, FACP Department of Clinical Epidemiology, Graduate School of Medicine, Fukushima Medical University, 1 Hikarigaoka, Fukushima City, Fukushima 960-1295, Japan kuritanoriaki@gmail.com
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Takanori Ichikawa
Sources of support: This study was supported by the JSPS KAKENHI (Grant Number: JP 19KT0021). The funder had no role in the study design, analyses, or interpretation of the data; writing of the manuscript; or the decision to submit it for publication. Oguro, N., MD, PhD. Division of Rheumatology, Department of Medicine, Showa University School of Medicine; Department of Clinical Epidemiology, Graduate School of Medicine, Fukushima Medical University. Yajima, N., MD, PhD. Division of Rheumatology, Department of Medicine, Showa University School of Medicine; Center for Innovative Research for Communities and Clinical Excellence, Fukushima Medical University; Department of Clinical Epidemiology, Kochi Medical School, Kochi University. Miyawaki, Y., MD, PhD. Department of Nephrology, Rheumatology, Endocrinology and Metabolism, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences. Yoshimi, R., MD, PhD. Department of Stem Cell and Immune Regulation, Yokohama City University Graduate School of Medicine. Shimojima Y., MD, PhD. Department of Medicine (Neurology and Rheumatology), Shinshu University School of Medicine. Sada K., MD, PhD. Department of Nephrology, Rheumatology, Endocrinology and Metabolism, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences; Department of Clinical Epidemiology, Kochi Medical School, Kochi University. Hayashi K., MD, PhD. Department of Nephrology, Rheumatology, Endocrinology and Metabolism, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences. Shidahara, K., MD. Department of Nephrology, Rheumatology, Endocrinology and Metabolism, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences. Sakurai N., MD. Department of Stem Cell and Immune Regulation, Yokohama City University Graduate School of Medicine. Hidekawa C., MD. Center for Rheumatic Diseases, Yokohama City University Medical Center. Kishida D., MD, PhD. Department of Medicine (Neurology and Rheumatology), Shinshu University School of Medicine. Ichikawa T., MD, PhD. Department of Medicine (Neurology and Rheumatology), Shinshu University School of Medicine. Ishikawa Y., MD. The First Department of Internal Medicine, School of Medicine, University of Occupational and Environmental Health. Kurita N., MD, PhD. Department of Clinical Epidemiology, Graduate School of Medicine, Fukushima Medical University; Department of Innovative Research and Education for Clinicians and Trainees (DiRECT), Fukushima Medical University Hospital. Conflict of interests: NK is a member of the Committee on Clinical Research, Japan College of Rheumatology and has received grants from the Japan Society for the Promotion of Science, consulting fees from GlaxoSmithKline K.K., and payment for speaking and educational events from Chugai Pharmaceutical Co. Ltd., Sanofi K.K., Mitsubishi Tanabe Pharma Corporation, and the Japan College of Rheumatology. KS has received a research grant from Pfizer Inc. and payment for speaking and educational events from GlaxoSmithKline K.K. Other authors declare no competing interests. Corresponding author: Noriaki Kurita, MD, PhD, FACP Department of Clinical Epidemiology, Graduate School of Medicine, Fukushima Medical University, 1 Hikarigaoka, Fukushima City, Fukushima 960-1295, Japan kuritanoriaki@gmail.com
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Yuichi Ishikawa
Sources of support: This study was supported by the JSPS KAKENHI (Grant Number: JP 19KT0021). The funder had no role in the study design, analyses, or interpretation of the data; writing of the manuscript; or the decision to submit it for publication. Oguro, N., MD, PhD. Division of Rheumatology, Department of Medicine, Showa University School of Medicine; Department of Clinical Epidemiology, Graduate School of Medicine, Fukushima Medical University. Yajima, N., MD, PhD. Division of Rheumatology, Department of Medicine, Showa University School of Medicine; Center for Innovative Research for Communities and Clinical Excellence, Fukushima Medical University; Department of Clinical Epidemiology, Kochi Medical School, Kochi University. Miyawaki, Y., MD, PhD. Department of Nephrology, Rheumatology, Endocrinology and Metabolism, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences. Yoshimi, R., MD, PhD. Department of Stem Cell and Immune Regulation, Yokohama City University Graduate School of Medicine. Shimojima Y., MD, PhD. Department of Medicine (Neurology and Rheumatology), Shinshu University School of Medicine. Sada K., MD, PhD. Department of Nephrology, Rheumatology, Endocrinology and Metabolism, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences; Department of Clinical Epidemiology, Kochi Medical School, Kochi University. Hayashi K., MD, PhD. Department of Nephrology, Rheumatology, Endocrinology and Metabolism, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences. Shidahara, K., MD. Department of Nephrology, Rheumatology, Endocrinology and Metabolism, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences. Sakurai N., MD. Department of Stem Cell and Immune Regulation, Yokohama City University Graduate School of Medicine. Hidekawa C., MD. Center for Rheumatic Diseases, Yokohama City University Medical Center. Kishida D., MD, PhD. Department of Medicine (Neurology and Rheumatology), Shinshu University School of Medicine. Ichikawa T., MD, PhD. Department of Medicine (Neurology and Rheumatology), Shinshu University School of Medicine. Ishikawa Y., MD. The First Department of Internal Medicine, School of Medicine, University of Occupational and Environmental Health. Kurita N., MD, PhD. Department of Clinical Epidemiology, Graduate School of Medicine, Fukushima Medical University; Department of Innovative Research and Education for Clinicians and Trainees (DiRECT), Fukushima Medical University Hospital. Conflict of interests: NK is a member of the Committee on Clinical Research, Japan College of Rheumatology and has received grants from the Japan Society for the Promotion of Science, consulting fees from GlaxoSmithKline K.K., and payment for speaking and educational events from Chugai Pharmaceutical Co. Ltd., Sanofi K.K., Mitsubishi Tanabe Pharma Corporation, and the Japan College of Rheumatology. KS has received a research grant from Pfizer Inc. and payment for speaking and educational events from GlaxoSmithKline K.K. Other authors declare no competing interests. Corresponding author: Noriaki Kurita, MD, PhD, FACP Department of Clinical Epidemiology, Graduate School of Medicine, Fukushima Medical University, 1 Hikarigaoka, Fukushima City, Fukushima 960-1295, Japan kuritanoriaki@gmail.com
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Noriaki Kurita
Sources of support: This study was supported by the JSPS KAKENHI (Grant Number: JP 19KT0021). The funder had no role in the study design, analyses, or interpretation of the data; writing of the manuscript; or the decision to submit it for publication. Oguro, N., MD, PhD. Division of Rheumatology, Department of Medicine, Showa University School of Medicine; Department of Clinical Epidemiology, Graduate School of Medicine, Fukushima Medical University. Yajima, N., MD, PhD. Division of Rheumatology, Department of Medicine, Showa University School of Medicine; Center for Innovative Research for Communities and Clinical Excellence, Fukushima Medical University; Department of Clinical Epidemiology, Kochi Medical School, Kochi University. Miyawaki, Y., MD, PhD. Department of Nephrology, Rheumatology, Endocrinology and Metabolism, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences. Yoshimi, R., MD, PhD. Department of Stem Cell and Immune Regulation, Yokohama City University Graduate School of Medicine. Shimojima Y., MD, PhD. Department of Medicine (Neurology and Rheumatology), Shinshu University School of Medicine. Sada K., MD, PhD. Department of Nephrology, Rheumatology, Endocrinology and Metabolism, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences; Department of Clinical Epidemiology, Kochi Medical School, Kochi University. Hayashi K., MD, PhD. Department of Nephrology, Rheumatology, Endocrinology and Metabolism, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences. Shidahara, K., MD. Department of Nephrology, Rheumatology, Endocrinology and Metabolism, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences. Sakurai N., MD. Department of Stem Cell and Immune Regulation, Yokohama City University Graduate School of Medicine. Hidekawa C., MD. Center for Rheumatic Diseases, Yokohama City University Medical Center. Kishida D., MD, PhD. Department of Medicine (Neurology and Rheumatology), Shinshu University School of Medicine. Ichikawa T., MD, PhD. Department of Medicine (Neurology and Rheumatology), Shinshu University School of Medicine. Ishikawa Y., MD. The First Department of Internal Medicine, School of Medicine, University of Occupational and Environmental Health. Kurita N., MD, PhD. Department of Clinical Epidemiology, Graduate School of Medicine, Fukushima Medical University; Department of Innovative Research and Education for Clinicians and Trainees (DiRECT), Fukushima Medical University Hospital. Conflict of interests: NK is a member of the Committee on Clinical Research, Japan College of Rheumatology and has received grants from the Japan Society for the Promotion of Science, consulting fees from GlaxoSmithKline K.K., and payment for speaking and educational events from Chugai Pharmaceutical Co. Ltd., Sanofi K.K., Mitsubishi Tanabe Pharma Corporation, and the Japan College of Rheumatology. KS has received a research grant from Pfizer Inc. and payment for speaking and educational events from GlaxoSmithKline K.K. Other authors declare no competing interests. Corresponding author: Noriaki Kurita, MD, PhD, FACP Department of Clinical Epidemiology, Graduate School of Medicine, Fukushima Medical University, 1 Hikarigaoka, Fukushima City, Fukushima 960-1295, Japan kuritanoriaki@gmail.com
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • Supplemental
  • Info & Metrics
  • References
  • PDF
PreviousNext
Loading

Abstract

Objective Patients who trust their physicians have been shown to demonstrate good medication adherence, self-management, and favorable disease outcomes. This study examines how trust in physicians is affected by functional health literacy (HL) and by broader concepts of HL, including communicative HL and critical HL among patients with systemic lupus erythematosus (SLE).

Methods This was a cross-sectional study using baseline data from the TRUMP2-SLE study, an ongoing multicenter cohort study conducted at five academic centers. The 14-item Functional Communicative Critical Health Literacy Scale assessed the three dimensions of HL (range: 1-4 points). Outcomes were trust in one's physician and physicians generally using the 5-item Wake Forest Physician Trust Scale (range: 0-100 points). General linear models were fit.

Results A total of 362 SLE patients were included. Trust in one's physician increased with higher functional and communicative HL (per 1-pt increase, 3.21 [95%CI 0.61, 5.81], 5.8 [95%CI 1.96, 9.63]). Trust in physicians in general increased with higher communicative HL and decreased with higher critical HL (per 1-pt increase, 7.01 [95%CI 2.27, 11.76], -6.83 [95%CI -11.67, -1.99]). Longer internet use was associated with both higher communicative and critical HL.

Conclusion The findings suggest that rheumatologists need to improve their communication to match each patient's health literacy, which may foster trust and lead to improved self-management and outcome in SLE. They also suggest that the formation of the rheumatologist-patient relationship may negate the effect of high critical HL in building trust.

PreviousNext
Back to top

In this issue

The Journal of Rheumatology: 52 (7)
The Journal of Rheumatology
Vol. 52, Issue 7
1 Jul 2025
  • Table of Contents
  • Table of Contents (PDF)
  • Index by Author
  • Editorial Board (PDF)
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word about The Journal of Rheumatology.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Impact of communicative and critical health literacy on trust in physicians among patients with systemic lupus erythematosus: the TRUMP2-SLE project
(Your Name) has forwarded a page to you from The Journal of Rheumatology
(Your Name) thought you would like to see this page from the The Journal of Rheumatology web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
Accepted manuscript
Impact of communicative and critical health literacy on trust in physicians among patients with systemic lupus erythematosus: the TRUMP2-SLE project
Nao Oguro, Nobuyuki Yajima, Yoshia Miyawaki, Ryusuke Yoshimi, Yasuhiro Shimojima, Ken-ei Sada, Keigo Hayashi, Kenta Shidahara, Natsuki Sakurai, Chiharu Hidekawa, Dai Kishida, Takanori Ichikawa, Yuichi Ishikawa, Noriaki Kurita
The Journal of Rheumatology Nov 2022, jrheum.220678; DOI: 10.3899/jrheum.220678

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero

 Request Permissions

Share
Accepted manuscript
Impact of communicative and critical health literacy on trust in physicians among patients with systemic lupus erythematosus: the TRUMP2-SLE project
Nao Oguro, Nobuyuki Yajima, Yoshia Miyawaki, Ryusuke Yoshimi, Yasuhiro Shimojima, Ken-ei Sada, Keigo Hayashi, Kenta Shidahara, Natsuki Sakurai, Chiharu Hidekawa, Dai Kishida, Takanori Ichikawa, Yuichi Ishikawa, Noriaki Kurita
The Journal of Rheumatology Nov 2022, jrheum.220678; DOI: 10.3899/jrheum.220678
del.icio.us logo Twitter logo Facebook logo  logo Mendeley logo
  • Tweet Widget
  •  logo
Bookmark this article

Jump to section

  • Article
  • Figures & Data
  • Supplemental
  • Info & Metrics
  • References
  • PDF

Related Articles

Cited By...

More in this TOC Section

  • Results of a Nationwide Multicenter Study in Childhood Sjögren Disease
  • Antimicrobial use and serious infections among psoriatic arthritis patients after initiating tumor necrosis factor inhibitors: a nationwide matched cohort study
  • Necrotizing and non-Necrotizing Granulomatous Reactions in Cancer Patients Treated with Immune Checkpoint Inhibitors: a Systematic Literature Review
Show more Accepted Articles

Similar Articles

Content

  • First Release
  • Current
  • Archives
  • Collections
  • Audiovisual Rheum
  • COVID-19 and Rheumatology

Resources

  • Guide for Authors
  • Submit Manuscript
  • Author Payment
  • Reviewers
  • Advertisers
  • Classified Ads
  • Reprints and Translations
  • Permissions
  • Meetings
  • FAQ
  • Policies

Subscribers

  • Subscription Information
  • Purchase Subscription
  • Your Account
  • Terms and Conditions

More

  • About Us
  • Contact Us
  • My Alerts
  • My Folders
  • Privacy/GDPR Policy
  • RSS Feeds
The Journal of Rheumatology
The content of this site is intended for health care professionals.
Copyright © 2025 by The Journal of Rheumatology Publishing Co. Ltd.
Print ISSN: 0315-162X; Online ISSN: 1499-2752
Powered by HighWire